Please enable JavaScript to continue using this application.

Compare $KOD vs $MIRM | Chartloom

Compare

$KOD vs $MIRM

Kodiak Sciences Inc · Mirum Pharmaceuticals Inc

KOD

Kodiak Sciences Inc

MIRM

Mirum Pharmaceuticals Inc

Compare $KOD vs $MIRM

Comparing Kodiak Sciences Inc and Mirum Pharmaceuticals Inc

KODKodiak Sciences Inc

MIRMMirum Pharmaceuticals Inc

KODKodiak Sciences Inc

Market cap

$6.25B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

283.8%

52W performance

590.7%

FCF yield

-2.6%

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KOD

MIRM

Detailed metrics comparison

KOD

Kodiak Sciences Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

KOD$6.25B

MIRM$5.24B

Enterprise Value

KOD$6.12B

MIRM$5.66B

Price

KOD$99.87

MIRM$86.01

P/E Ratio

KODN/A

MIRMN/A

P/S Ratio

KOD0.00x

MIRM8.49x

EV/Sales

KOD0.00x

MIRM9.16x

EV/EBITDA

KOD0.00x

MIRM2,753.41x

P/B Ratio

KOD97.16x

MIRM22.21x

P/FCF Ratio

KODN/A

MIRMN/A

EV/FCF

KOD-38.30x

MIRM-21.48x

PEG Ratio

KODN/A

MIRMN/A

Forward P/E (NTM)

KODN/A

MIRMN/A

Forward P/S (NTM)

KODN/A

MIRM6.85x

Revenue (TTM)

KOD$0

MIRM$618M

Revenue Growth (YoY)

KODN/A

MIRM44.0%

Forward Rev Growth

KOD455.7%

MIRM17.0%

Gross Margin (TTM)

KOD0.0%

MIRM81.7%

Operating Margin (TTM)

KOD0.0%

MIRM0.0%

EBITDA Margin (TTM)

KOD0.0%

MIRM-10.6%

Net Margin (TTM)

KOD0.0%

MIRM-139.2%

FCF Margin (TTM)

KODN/A

MIRM-42.7%

Net Income (TTM)

KOD$-242M

MIRM$-860M

FCF (TTM)

KOD$-160M

MIRM$-264M

EPS (TTM)

KOD-$3.86

MIRM-$13.57

ROE (TTM)

KOD-27323.0%

MIRM-28933.0%

ROA (TTM)

KOD-8548.0%

MIRM-9655.0%

ROIC (TTM)

KOD-27323.0%

MIRM-13639.0%

Cash

KOD$126M

MIRM$331M

Debt

KOD$0

MIRM$750M

Net Cash/Debt

KOD$126M

MIRM$-419M

Current Ratio (TTM)

KOD2.49x

MIRM2.86x

Quick Ratio (TTM)

KOD2.39x

MIRM2.62x

Debt/Equity (TTM)

KOD0.00x

MIRM1.28x

Debt/Assets (TTM)

KOD0.0%

MIRM0.0%

Interest Coverage (TTM)

KODN/A

MIRMN/A

Net Debt/EBITDA (TTM)

KOD0.00x

MIRM0.00x

Beta

KOD1.95

MIRM0.75

52W Performance

KOD590.7%

MIRM18.1%

YTD Performance

KOD283.8%

MIRM10.2%

% from 52W High

KOD-4.0%

MIRM-33.8%

% from 52W Low

KOD812.9%

MIRM36.0%

Asset Turnover (TTM)

KOD0.00x

MIRM0.69x

FCF Yield (TTM)

KOD-2.6%

MIRM-5.0%

Earnings Yield (TTM)

KOD-3.9%

MIRM-16.4%

Dividend Yield (TTM)

KODN/A

MIRMN/A

Rule of 40

KOD0.0

MIRM1.3

EV/GP/RG

KODN/A

MIRM0.45

Ticker research

View KOD research View MIRM research

Metric	KOD Kodiak Sciences Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.25B	$5.24B
Enterprise Value	$6.12B	$5.66B
Price	$99.87	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.49x
EV/Sales	0.00x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	97.16x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.30x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.85x
Revenue & Growth
Revenue (TTM)	$0	$618M
Revenue Growth (YoY)	N/A	44.0%
Forward Rev Growth	455.7%	17.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-10.6%
Net Margin (TTM)	0.0%	-139.2%
FCF Margin (TTM)	N/A	-42.7%
Net Income (TTM)	$-242M	$-860M
FCF (TTM)	$-160M	$-264M
EPS (TTM)	-$3.86	-$13.57
ROE (TTM)	-27323.0%	-28933.0%
ROA (TTM)	-8548.0%	-9655.0%
ROIC (TTM)	-27323.0%	-13639.0%
Financial Health
Cash	$126M	$331M
Debt	$0	$750M
Net Cash/Debt	$126M	$-419M
Current Ratio (TTM)	2.49x	2.86x
Quick Ratio (TTM)	2.39x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.75
52W Performance	590.7%	18.1%
YTD Performance	283.8%	10.2%
% from 52W High	-4.0%	-33.8%
% from 52W Low	812.9%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-2.6%	-5.0%
Earnings Yield (TTM)	-3.9%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1.3
EV/GP/RG	N/A	0.45
Ticker research	View KOD research	View MIRM research

Valuation

P/S Ratio

KOD

0.00x

MIRM

8.49x

EV/FCF

KOD

-38.30x

MIRM

-21.48x

Growth & revenue

Revenue Growth TTM

MIRM

44.0%

Forward Revenue Growth

KOD

455.7%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

KOD

0.0%

ROE

KOD

-27323.0%

MIRM

-28933.0%

FCF Yield %

KOD

-2.6%

MIRM

-5.0%

52-Week Performance

KOD

590.7%

MIRM

18.1%

Detailed metrics comparison

KOD

Kodiak Sciences Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

KOD$6.25B

MIRM$5.24B

Enterprise Value

KOD$6.12B

MIRM$5.66B

Price

KOD$99.87

MIRM$86.01

P/E Ratio

KODN/A

MIRMN/A

P/S Ratio

KOD0.00x

MIRM8.49x

EV/Sales

KOD0.00x

MIRM9.16x

EV/EBITDA

KOD0.00x

MIRM2,753.41x

P/B Ratio

KOD97.16x

MIRM22.21x

P/FCF Ratio

KODN/A

MIRMN/A

EV/FCF

KOD-38.30x

MIRM-21.48x

PEG Ratio

KODN/A

MIRMN/A

Forward P/E (NTM)

KODN/A

MIRMN/A

Forward P/S (NTM)

KODN/A

MIRM6.85x

Revenue (TTM)

KOD$0

MIRM$618M

Revenue Growth (YoY)

KODN/A

MIRM44.0%

Forward Rev Growth

KOD455.7%

MIRM17.0%

Gross Margin (TTM)

KOD0.0%

MIRM81.7%

Operating Margin (TTM)

KOD0.0%

MIRM0.0%

EBITDA Margin (TTM)

KOD0.0%

MIRM-10.6%

Net Margin (TTM)

KOD0.0%

MIRM-139.2%

FCF Margin (TTM)

KODN/A

MIRM-42.7%

Net Income (TTM)

KOD$-242M

MIRM$-860M

FCF (TTM)

KOD$-160M

MIRM$-264M

EPS (TTM)

KOD-$3.86

MIRM-$13.57

ROE (TTM)

KOD-27323.0%

MIRM-28933.0%

ROA (TTM)

KOD-8548.0%

MIRM-9655.0%

ROIC (TTM)

KOD-27323.0%

MIRM-13639.0%

Cash

KOD$126M

MIRM$331M

Debt

KOD$0

MIRM$750M

Net Cash/Debt

KOD$126M

MIRM$-419M

Current Ratio (TTM)

KOD2.49x

MIRM2.86x

Quick Ratio (TTM)

KOD2.39x

MIRM2.62x

Debt/Equity (TTM)

KOD0.00x

MIRM1.28x

Debt/Assets (TTM)

KOD0.0%

MIRM0.0%

Interest Coverage (TTM)

KODN/A

MIRMN/A

Net Debt/EBITDA (TTM)

KOD0.00x

MIRM0.00x

Beta

KOD1.95

MIRM0.75

52W Performance

KOD590.7%

MIRM18.1%

YTD Performance

KOD283.8%

MIRM10.2%

% from 52W High

KOD-4.0%

MIRM-33.8%

% from 52W Low

KOD812.9%

MIRM36.0%

Asset Turnover (TTM)

KOD0.00x

MIRM0.69x

FCF Yield (TTM)

KOD-2.6%

MIRM-5.0%

Earnings Yield (TTM)

KOD-3.9%

MIRM-16.4%

Dividend Yield (TTM)

KODN/A

MIRMN/A

Rule of 40

KOD0.0

MIRM1.3

EV/GP/RG

KODN/A

MIRM0.45

Ticker research

View KOD research View MIRM research

Metric	KOD Kodiak Sciences Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.25B	$5.24B
Enterprise Value	$6.12B	$5.66B
Price	$99.87	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.49x
EV/Sales	0.00x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	97.16x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.30x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.85x
Revenue & Growth
Revenue (TTM)	$0	$618M
Revenue Growth (YoY)	N/A	44.0%
Forward Rev Growth	455.7%	17.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-10.6%
Net Margin (TTM)	0.0%	-139.2%
FCF Margin (TTM)	N/A	-42.7%
Net Income (TTM)	$-242M	$-860M
FCF (TTM)	$-160M	$-264M
EPS (TTM)	-$3.86	-$13.57
ROE (TTM)	-27323.0%	-28933.0%
ROA (TTM)	-8548.0%	-9655.0%
ROIC (TTM)	-27323.0%	-13639.0%
Financial Health
Cash	$126M	$331M
Debt	$0	$750M
Net Cash/Debt	$126M	$-419M
Current Ratio (TTM)	2.49x	2.86x
Quick Ratio (TTM)	2.39x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.75
52W Performance	590.7%	18.1%
YTD Performance	283.8%	10.2%
% from 52W High	-4.0%	-33.8%
% from 52W Low	812.9%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-2.6%	-5.0%
Earnings Yield (TTM)	-3.9%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	1.3
EV/GP/RG	N/A	0.45
Ticker research	View KOD research	View MIRM research